Total Payments
$2,000
2024 Payments
$594.98
Companies
26
Transactions
102
Medicare Patients
2,742
Medicare Billing
$181,020
Payment Breakdown by Category
Food & Beverage$1,900 (95.0%)
Education$99.62 (5.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,900 | 100 | 95.0% |
| Education | $99.62 | 2 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $349.16 | 18 | $0 (2024) |
| Astellas Pharma US Inc | $215.47 | 10 | $0 (2024) |
| ABBVIE INC. | $207.30 | 12 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $175.08 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $166.23 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $140.10 | 8 | $0 (2024) |
| Tolmar, Inc. | $68.26 | 3 | $0 (2024) |
| Blue Earth Diagnostics Limited | $64.31 | 2 | $0 (2019) |
| UROVANT SCIENCES INC | $58.15 | 3 | $0 (2022) |
| 180 Medical, Inc. | $56.28 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $594.98 | 28 | Sumitomo Pharma America, Inc. ($151.88) |
| 2023 | $260.40 | 13 | PFIZER INC. ($37.47) |
| 2022 | $363.30 | 15 | PFIZER INC. ($164.07) |
| 2020 | $15.21 | 1 | NeoTract Inc. ($15.21) |
| 2019 | $189.21 | 11 | PFIZER INC. ($30.61) |
| 2018 | $353.84 | 21 | Astellas Pharma US Inc ($81.86) |
| 2017 | $223.17 | 13 | Rochester Medical Corporation ($37.13) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: UROLOGY | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $18.73 | General |
| 09/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: UROLOGY | ||||||
| 09/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: UROLOGY | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Oncology | ||||||
| 08/14/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Oncology | ||||||
| 07/24/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: UROLOGY | ||||||
| 06/26/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: UROTHELIAL CANCER | ||||||
| 06/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: UROLOGY | ||||||
| 06/07/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Oncology | ||||||
| 05/29/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: ONCOLOGY | ||||||
| 05/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: UROLOGY | ||||||
| 05/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: ONCOLOGY | ||||||
| 04/15/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $28.46 | General |
| 04/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: UROLOGY | ||||||
| 03/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 759 | 874 | $205,733 | $47,413 |
| 2022 | 12 | 759 | 847 | $204,609 | $50,275 |
| 2021 | 12 | 689 | 760 | $187,113 | $49,774 |
| 2020 | 11 | 535 | 596 | $141,644 | $33,559 |
Total Patients
2,742
Total Services
3,077
Medicare Billing
$181,020
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 221 | 279 | $59,171 | $19,161 | 32.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 128 | 147 | $61,786 | $8,442 | 13.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 94 | 94 | $30,174 | $7,844 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 87 | 91 | $12,922 | $4,429 | 34.3% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 13 | 13 | $6,373 | $1,217 | 19.1% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Facility | 2023 | 55 | 55 | $6,272 | $1,027 | 16.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 32 | 39 | $3,491 | $970.20 | 27.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 12 | $2,400 | $776.52 | 32.4% |
| 51702 | Simple insertion of temporary bladder tube | Facility | 2023 | 13 | 35 | $4,405 | $680.40 | 15.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 14 | $1,988 | $603.36 | 30.4% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Facility | 2023 | 20 | 20 | $4,419 | $476.95 | 10.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 16 | 18 | $1,512 | $464.27 | 30.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 12 | 12 | $2,508 | $412.78 | 16.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 17 | 17 | $5,205 | $405.60 | 7.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 12 | 13 | $1,846 | $257.75 | 14.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2023 | 15 | 15 | $1,260 | $245.79 | 19.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 207 | 252 | $53,528 | $16,617 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 122 | 122 | $39,804 | $10,642 | 26.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 127 | 133 | $56,000 | $8,040 | 14.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 58 | 69 | $14,421 | $4,343 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 67 | 70 | $9,940 | $3,382 | 34.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 26 | 26 | $5,200 | $2,052 | 39.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 37 | 41 | $5,822 | $1,713 | 29.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 19 | 19 | $3,937 | $964.08 | 24.5% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Facility | 2022 | 42 | 42 | $4,790 | $868.34 | 18.1% |
About Dr. Harry Slatch, M.D
Dr. Harry Slatch, M.D is a Urology healthcare provider based in Glens Falls, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1194875310.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harry Slatch, M.D has received a total of $2,000 in payments from pharmaceutical and medical device companies, with $594.98 received in 2024. These payments were reported across 102 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,900).
As a Medicare-enrolled provider, Slatch has provided services to 2,742 Medicare beneficiaries, totaling 3,077 services with total Medicare billing of $181,020. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Glens Falls, NY
- Active Since 01/11/2007
- Last Updated 02/21/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1194875310
Products in Payments
- XTANDI (Drug) $344.73
- GEMTESA (Drug) $233.23
- KEYTRUDA (Biological) $145.37
- BOTOX (Biological) $116.72
- ELIGARD (Drug) $106.17
- Myrbetriq (Drug) $91.80
- Erleada (Drug) $89.64
- Axumin (Drug) $64.31
- TOVIAZ (Drug) $62.75
- Lupron (Drug) $60.29
- PLUVICTO (Drug) $50.49
- ERLEADA (Drug) $50.46
- UroLift (Device) $45.48
- Xtandi (Drug) $41.81
- AVEED (Biological) $38.29
- BMD-Magic3 Catheter (Device) $37.13
- INTERSTIM (Device) $36.95
- UROLIFT (Device) $28.50
- Androgel (Drug) $26.72
- GENERAL BPH (Device) $26.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.